Dova Pharmaceuticals Profile

Performance

1313
   

Odds of Distress

Check how we calculate scores
Equity ratings for Dova Pharmaceuticals are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting June 21, 2019 and ending today September 19, 2019. Click here to learn more.

Dova Pharmaceuticals Summary

Dova Pharmaceuticals (DOVA) is traded on BATS Exchange in USA. It is located in 240 Leigh Farm Road and employs 115 people. Dova Pharmaceuticals is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 477.54M. Dova Pharmaceuticals conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 28.8M outstanding shares of which 2.63M shares are currently shorted by private and institutional investors with about 10.38 trading days to cover. The company currently holds about 76.78M in cash with (57.88M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.67.
Check Dova Pharmaceuticals Probability Of Bankruptcy

Ownership Allocation (%)

Dova Pharmaceuticals Target Price Odds Analysis

Odds Below 16.03HorizonTargetOdds Above 16.03
69.20%30 days 16.03 30.70%
Based on normal probability distribution, the odds of Dova Pharmaceuticals to move above current price in 30 days from now is about 30.7% (This Dova Pharmaceuticals probability density function shows the probability of Dova Pharmaceuticals Stock to fall within a particular range of prices over 30 days) .

Dova Pharmaceuticals Top Holders

Dova Pharmaceuticals Income Statement Over Time

Direct Expenses    Earning Before Interest and Taxes EBIT    Net Income    

Dova Pharmaceuticals Key Fundamentals

Dova Pharmaceuticals Against Markets

Dova Pharmaceuticals Vital Trading Data

Dova Pharmaceuticals, Inc., a pharmaceutical company, focuses on acquiring, developing, and commercializing drug candidates for thrombocytopenia disease. Dova Pharmaceuticals, Inc. was founded in 2016 and is headquartered in Durham, North Carolina. Dova Pharmaceuticals operates under Biotechnology classification in USA and is traded on BATS Exchange. It employs 115 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Dova Pharmaceuticals SEC Filings
Dova Pharmaceuticals SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameDova Pharmaceuticals
President CEO, DirectorAlex SapirView All
Thematic Classification
Currently Active Investing Idea
  Pharmaceutical Products
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
RegionNorth America
LocationNorth Carolina U.S.A
Business Address240 Leigh Farm Road
ExchangeBATS Exchange
CIK Number0001685071
CUSIP25985T102
SectorHealthcare
IndustryBiotechnology
BenchmarkDOW
Websitewww.dova.com
Phone919 748 5975
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterJune 30, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestAugust 15, 2019

Dova Pharmaceuticals Corporate Directors

Steven Goldman Independent Director
Alfred Novak Independent Director
Sean Stalfort Director
Additionally see Investing Opportunities. Please also try Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.
Search macroaxis.com